Actelion
AcquiredJohnson & Johnson Innovative Medicine
Allschwil, Switzerland · Founded 1997 · $46.0M raised
- Headquarters
- Allschwil
- Employees
- 1001–5000
- Founded
- 1997
- Business Model
- B2B
- Website
- actelion.com
- Total Funding
- $46.0M
- Last Round
- $34.0M Series B
- Rounds
- 2
About
Actelion Pharmaceuticals Ltd. is a Swiss biopharmaceutical company founded in 1997 and headquartered in Allschwil, near Basel, Switzerland. The company specialized in the discovery, development, and commercialization of drugs for rare and orphan diseases, with a primary focus on pulmonary arterial hypertension (PAH). Its key products include Tracleer (bosentan), the first oral therapy approved for PAH; Opsumit (macitentan); Uptravi (selexipag); Ventavis (iloprost); and Veletri (epoprostenol). In January 2017, Johnson & Johnson acquired Actelion for billion, and Actelion's R&D unit was spun off as Idorsia, listed on the SIX Swiss Exchange in June 2017.
Summary
Actelion is a Biotechnology company based in Allschwil, Switzerland, founded in 1997. It has raised $46.0M in total across 2 rounds. Investors include TVM Capital and Atlas Venture.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Unknown
Sign up to see all 2 rounds
Series B through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Novel vaccine platform
Biotech company developing novel GPCR-targeting therapeutics using conformation-specific nanobodies.
Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...
Breakthrough technology for the oral delivery of biologics
BridgeBio makes targeted treatments for genetic diseases.
Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/actelion"><img src="https://indexed.vc/api/badge/company/actelion" alt="Actelion on Indexed.vc" width="260" height="76" /></a>